FDA Staff on Commissioner’s Voucher Program Concerns-AP

AP reporting on FDA drug reviews and Commissioner's voucher program Matthew Perrone here with the Associated Press, where I have covered the FDA and US health policy for nearly two decades. I’m working on a story about the FDA Commissioner’s National Priority Voucher program and would love to connect with FDA staff familiar with this effort. What are the scientific, legal and ethical concerns raised by the initiative? How has the rollout and handling of this program differed from traditional expedited pathways? Is it interfering with other agency reviews and priorities? As always, we will protect your identity and only share the information you wish to make public. The Associated Press is an independent global news organization dedicated to factual, nonpartisan journalism. Unlike nearly every other news outlet covering the FDA, our stories are always free and never behind a paywall. We serve thousands of websites, newspapers, radio and TV stations in US and around the world. You can reach me on Signal at MattLPerrone.82 or via email at [email redacted]. My phone number is (202) 641-9863. Thank you and hope to hear from you.